Objective-Serum response factor (SRF) is a critical transcription factor in smooth muscle cells (SMCs) controlling differentiation and proliferation. Our previous work demonstrated that depleting SRF in cultured SMCs decreased expression of SMC markers but increased proliferation and inflammatory mediators. A similar phenotype has been observed in SMCs silenced for phosphatase and tensin homolog (PTEN), suggesting that SRF and PTEN may lie on a common pathway. Our goal was to determine the effect of SRF depletion on PTEN levels and define mechanisms mediating this effect. Methods and Results-In SRF-silenced SMCs, PTEN protein levels but not mRNA levels were decreased, suggesting posttranscriptional regulation. Reintroduction of PTEN into SRF-depleted SMCs reversed increases in proliferation and cytokine/chemokine production but had no effect on SMC marker expression. SRF-depleted cells showed decreased levels of microRNA (miR)-143 and increased miR-21, which was sufficient to suppress PTEN. Increased miR-21 expression was dependent on induction of Fos related antigen (FRA)-1, which is a direct target of miR-143. Introducing miR-143 into SRF-depleted SMCs reduced FRA-1 expression and miR-21 levels and restored PTEN expression.
C ardiovascular-related diseases are the leading cause of death in industrialized nations. Pathological and physiological insults to vessels result in vascular remodeling and intimal hyperplasia, which contribute to the pathogenesis of diseases, such as atherosclerosis, restenosis, and pulmonary hypertension. Resident medial smooth muscle cells (SMCs) are the major cells involved in vessel remodeling. Under normal physiological conditions, SMCs display a quiescent, contractile, and differentiated phenotype. However, in response to pathological and physiological insults, these cells convert to an activated phenotype characterized by decreased smooth muscle (SM)-gene expression, increased proliferation and migration, and enhanced production of cytokines/chemokines and extracellular matrix. 1 Although much effort has been invested into understanding the molecular changes underlying SMC activation, defining repressive pathways actively inhibiting this process is an understudied area of research. SMC differentiation is defined by a collection of markers most of which are cytoskeletal proteins whose expression is selectively controlled at the transcriptional level. 2 However, recent studies have identified a role for noncoding regulatory microRNAs (miRNAs, miRs) in the regulation of SMC differentiation. miRNAs are 22 to 23 nucleotides long and target the 3Ј-untranslated region (UTR) of selective RNA transcripts, resulting in inhibition of translation or promotion of mRNA degradation. There is strong evidence that miRs play key roles in SMC development. 3 Furthermore, studies have suggested that miR dysregulation is a critical event in the progression of vascular diseases. Collectively, it appears that multiple mechanisms control SMC phenotype, and dysregulation of these processes may play a critical role in the development of activated SMCs that are involved in neointimal formation.
Serum response factor (SRF), a member of the MCMI, agamous, deficiens, SRF family of transcription factors, binds to CArG box elements in the promoter region of targeted genes. 4 Studies using conditional knockout models have shown that inactivation of SRF in SMCs and cardiac myocytes results in embryonic lethality, demonstrating that SRF is essential for vascular and cardiac development. 5 In SMCs, SRF directly regulates 2 classes of genes, SM markers (including smooth muscle ␣-actin [␣-SMA], calponin, and smooth muscle myosin heavy chain) and immediate early genes (such as c-fos). Tran-scriptional control of these classes of genes involves interactions between SRF and specific coactivators, including members of the myocardin family. 6 Recent data indicate that SRF also transcriptionally regulates specific miRs (eg, miR-143, miR-145) as a mechanism to control SM-gene expression and SMC differentiation. [7] [8] [9] Using an in vitro approach, we showed that depleting SRF in SMCs using specific short hairpin RNA (shRNA) constructs resulted in decreased SM-gene expression but, unexpectedly, also increased proliferation, migration, and extracellular matrix production, which are all hallmarks of activated SMCs. 10 The effect on proliferation in particular was unanticipated because depleting SRF would be predicted to result in decreased expression of immediate early genes, such as c-fos, leading to decreased proliferation.
Phosphatase and tensin homolog (PTEN) is a protein and lipid phosphatase that functions to suppress multiple pathways involved in cellular proliferation, survival, and inflammation. 11 The role of PTEN has been well characterized in cancer; however, its role in vascular disease is less well defined. Work by several groups has established that PTEN inactivation results in increased SMC proliferation and decreased cell death. [12] [13] [14] Furthermore, vascular injury results in SMC PTEN inactivation and is associated with increased neointima formation. 15 Recent work by our laboratory demonstrates that PTEN is a critical regulator of SMC function both in vivo and in vitro. SMC-specific knockout of PTEN in vivo results in a larger neointima in response to vessel wall injury because of increased proliferation and recruitment of inflammatory cells. 16 In vitro shRNA-dependent depletion of PTEN promotes an inflammatory SMC phenotype characterized by increased proliferation, decreased SM-gene expression, and increased inflammatory cytokine and chemokine production. 17 In addition, work by Ji et al suggested that miRs, such as miR-21, are differentially expressed by SMCs in the setting of vascular injury and that PTEN is a direct target of miR-21. 18 Furthermore, alteration of miR-21 in vivo is sufficient to regulate neointima formation.
Because depletion of either SRF or PTEN in SMCs in vitro results in similar phenotypes, we hypothesized that an SRF-PTEN signaling pathway existed to regulate SMC phenotype. In this study, we report that PTEN protein levels, but interestingly not mRNA levels, are decreased in SRF-silenced cells, suggesting posttranscriptional regulation of PTEN. Restoring PTEN levels using viral overexpression was sufficient to reverse the increased proliferation and elevated cytokine production observed in SRF-silenced SMCs but did not result in restoration of SM-specific gene expression. Our studies showed that, as expected, miR-143 and miR-145 levels are decreased in SRF-depleted SMCs, but miR-21 levels are increased. Furthermore, SRF-dependent regulation of miR-21 occurs transcriptionally through a miR-143-and Fos related antigen (FRA)-1-dependent signaling pathway. Loss of miR-143 in SRF-depleted SMCs resulted in FRA-1dependent induction of miR-21, leading to PTEN loss. Forced expression of miR-143 or depletion of FRA-1 in SRFdepleted SMCs reversed the induction of miR-21 and restored PTEN levels. Collectively, we propose that control of SMC dedifferentiation by SRF is complex involving direct transcriptional regulation of cytoskeletal proteins, as well as indirect regulation of proteins involved in proliferation and inflammation (eg, PTEN), through miR regulation.
Materials and Methods
An expanded Methods section is available in the supplemental materials, available online at http://atvb.ahajournals.org. Cell culture, proliferation, immunoblotting, SRF overexpression, and quantitative polymerase chain reaction were performed as previously described. 10, 16, 17, 19 Plasmids, transient promoter assays, adenovirus infections, miR quantitation, primer sequences, and statistical analyses are described in detail in the supplemental materials.
Results

Decreased PTEN Levels in SRF-Depleted SMCs
Previous work from our laboratory showed that depletion of SRF in aortic SMCs decreased SMC-gene expression and increased proliferation, migration, and extracellular matrix production, which are hallmarks of a dedifferentiated vascular SMCs. 20 Increased proliferative capacity observed in these cells was particularly surprising, given SRF's known role in regulating immediate early gene (IEG) expression. We postulated that loss of SRF might be regulating an alternative proliferative pathway even in the absence of IEG activation. Recent work from our laboratory showed that loss of PTEN in SMCs phenocopied many of the functional changes observed in SRFdepleted SMCs, including increased proliferation and cytokine production and decreased SM-gene expression. 16, 17 Thus, we hypothesized that SRF regulation of PTEN serves as a mechanism mediating these changes. Stable SMC clones expressing control (U6) or SRF (shSRF2 and shSRF6) shRNA 10 were analyzed for PTEN protein levels under basal conditions. Compared with controls, shSRF2 and shSRF6 expressed lower amounts of SRF and ␣-SMA 10 and ( Figure 1A ). Importantly, PTEN was decreased in both SRF-depleted SMC clones compared with control SMCs ( Figure 1A ). To validate that these results are not due to abnormal selection during isolation of shSRF clones, low-passage pools of SRF-depleted SMCs were generated using a lentiviral shRNA approach (shSRF4). Compared with controls (pGIPz), shSRF4 SMC pools also exhibited decreased PTEN levels similar to SRF-depleted SMC clones ( Figure 1B ). These cells also exhibited decreased levels of 2 known downstream targets of SRF, ␣-SMA and early growth response protein-1 (not shown), consistent with what was observed in the shRNA clones.
Increased Expression of PTEN Is Sufficient to Reverse Proliferative and Inflammatory Effects of SRF Depletion
To determine whether PTEN downregulation mediates the functional changes in SRF-depleted SMCs, U6 and shSRF2 SMCs were transduced with adenoviruses expressing empty vector or wild-type PTEN. Wild-type PTEN adenovirus restored PTEN protein levels in SRF-depleted SMCs to those observed in control SMCs ( Figure 1C ). By 5-bromo-2Јdeoxyuridine incorporation, the enhanced proliferation observed in SRF-depleted SMCs was decreased by PTEN restoration to levels observed in U6 control cells ( Figure 1D ).
Transcription profiling revealed that depletion of SRF resulted in induction of several proinflammatory chemokines, including monocyte chemoattractant protein-1 and keratino- Figure 1 . Decreased phosphatase and tensin homolog (PTEN) expression promotes proliferation and chemokine induction in serum response factor (SRF)-silenced smooth muscle cells (SMCs). A, Cell lysates prepared from SMC clones silenced for SRF expression (short hairpin [sh] SRF2, shSRF6) or control shRNA (U6) were immunoblotted for the indicated proteins. B, Pools of SMCs infected with a lentivirus shRNA construct against SRF (shSRF4) or control shRNA (pGIPz) were isolated, and lysates were immunoblotted for the indicated proteins. Shown in both A and B are representative Western blots and fold changes in densitometry measurementsϮSE from cyte chemoattractant (our unpublished data). In agreement with these data, mRNA levels assessed by quantitative reverse transcription-polymerase chain reaction were increased for monocyte chemoattractant protein-1 and keratinocyte chemoattractant in SRF-depleted SMCs compared with controls ( Figure 1E and 1F). PTEN restoration was sufficient to reverse the increase in monocyte chemoattractant protein-1 expression ( Figure 1E ) and blunt the increase in keratinocyte chemoattractant expression ( Figure 1F ) observed in SRFdepleted SMCs. In contrast, decreased ␣-SMA mRNA and protein expression observed in the setting of SRF depletion was not reversed by PTEN overexpression (Figure 1G and 1H). These data suggest that SRF-dependent regulation of PTEN mediates the proliferative and inflammatory SMC phenotype observed in response to SRF depletion, despite reductions in IEGs. 10
SRF Regulates PTEN Through miR-21
To determine whether the effects of SRF depletion on PTEN are transcriptionally mediated, we measured PTEN mRNA levels. Unexpectedly, PTEN mRNA in both shSRF clones and pools was elevated compared with their respective controls ( Figure 2A and 2B), suggesting posttranscriptional regulation of PTEN protein levels. One important mechanism of posttranscriptional regulation is through the activity of miRs. To assess the potential role of miRs, SMCs were transfected with a construct encoding the 3ЈUTR of PTEN linked to a luciferase reporter (PTEN 3ЈUTR-luc). Luciferase activity in both shSRF clones was decreased compared with U6 control cells ( Figure 2C ); conversely, transient overexpression of SRF in wild-type SMCs resulted in an increase in luciferase activity ( Figure 2D ). In contrast, inhibition of proteosomal degradation with MG132 inhibitor (Calbiochem) had no effect on PTEN protein levels but increased protein expression of p21Cip1, which is known to be sensitive to proteosomal degradation (not shown).
These data suggest that silencing of SRF inhibits PTEN expression through a miR-dependent mechanism. Although several miRs have been implicated in regulating PTEN, recent studies have demonstrated that miR-21 is a major regulator. 21 Ji et al reported that miR-21 was increased in vascular injury, and 1 of its primary downstream targets in SMCs was PTEN. 18 Consistent with these findings, overexpression of a miR-21 mimetic decreased expression of PTEN protein (Supplemental Figure IA) . To confirm a role for miR-21 in PTEN regulation, point mutations were introduced into the PTEN 3Ј-UTR corresponding to the miR-21 miRNA response element. 22 In SRF-depleted SMCs, a miR-21 inhibitor increased 3-UTR luciferase activity but failed to alter activity of the miR-21 miRNA response element mutated PTEN 3Ј-UTR (Supplemental Figure IB) . Consistent with these findings, miR-21 levels were elevated in SRF-depleted SMC clones ( Figure 2E ) and pools ( Figure 2F ) compared with their respective controls. In addition, levels of programmed cell death gene 4, another classical target of miR-21, 21 were decreased in SRF-depleted SMCs compared with U6 SMCs (Figure 2G and 2H).
SRF Negatively Regulates miR-21 Promoter Activity Through FRA-1
Because SRF has been shown to regulate several miRs at the promoter level, 8, 9 we examined SRF transcriptional regulation of miR-21. Recent work by Fujita et al 23 identified the putative promoter region of miR-21 (PPR-miR-21). We cloned this region into a PGL4.12 luciferase reporter (PPR-miR-21-luc) and measured luciferase activity in control and SRF-depleted SMCs. Luciferase activity normalized to ␤-galactosidase was increased in SRF-depleted SMCs compared with controls ( Figure 3A ), consistent with the increased miR-21 levels observed in these cells. Conversely, overexpression of SRF resulted in decreased PPR-miR-21-luc activity compared with control SMCs ( Figure 3B ).
Previous studies identified multiple AP-1 binding sites within the miR-21 promoter region as critical for regulating activity. 23 To determine whether these AP-1 binding sites are important for SRF regulation of PPR-mIR-21, truncation mutants of the promoter region were generated (PPR-miR-21-F2,F3) and transfected into control or SRF-depleted SMCs ( Figure 3C ). Increases in PPR-miR-21 luciferase activity in SRF-depleted SMCs were retained using the PPR-miR-21-F2 mutant, which lacks only 1 AP-1 site, but were blunted in cells transfected with the PPR-miR-21-luc-F3 mutant, which lacks 2 of 4 AP-1 sites. A putative SRF binding site has also been identified in the promoter, which is deleted in the F3 mutant. To preclude a direct role for SRF on repression of miR-21 activity, SMCs were cotransfected with SRF and either wild-type PPR-miR-21-Luc or PPR-mir-21-Luc containing a point mutation in the SRF binding site (S1). Overexpression of SRF decreased PPR-miR-21-Luc activity in SMCs cotransfected with both the wild-type and SRF mutant luciferase constructs ( Figure 3D ). Collectively, our data suggest that AP-1 binding sites, but not SRF binding sites, within the PPR-miR-21 are necessary for SRF-mediated negative regulation of miR-21 promoter activity.
SRF Regulates FRA-1 Through a miR-143 Dependent Regulation
AP-1 transcription factors are composed of c-fos and c-jun family members. Previous work by our laboratory showed that c-fos protein levels are greatly reduced in SRF depleted SMCs, 10 which is expected, as c-fos is a direct target of SRF. 24 However, c-jun levels are increased in these SRF depleted cells. 10 It was recently reported that other c-fos family members, such as FRA-1 and FRA-2, interact with c-jun to regulate miR-21 promoter activity. 23 Therefore, we determined whether increased expression of other c-fos family members in SRF-depleted cells could result in formation 
of heterodimers with c-jun that would increase miR-21 promoter activity in the setting of decreased c-fos. Microarray analysis indicated increased levels of FRA-1 in SRF depleted cells (data not shown). We confirmed this by Western blot analysis, showing increases in FRA-1 protein levels in both SRF-depleted clones ( Figure 3E ) and pools ( Figure 3F ) compared with their respective controls. A reduction in FRA-1 using small interfering RNA in SRF-depleted SMCs ( Figure 3G ) blocked miR-21 promoter activity ( Figure 3H ) and increased PTEN 3ЈUTR-luc activity ( Figure 3I ), confirming that FRA-1 is a critical regulator of the miR-21 promoter in the absence of SRF and c-fos. To define the mechanism by which SRF is regulating FRA-1, we used the microcosm miRNA targeting database (http://www.ebi.ac.uk/). We identified miR-143 as a mi-croRNA that potentially targets FRA-1, but not c-fos. Several groups have shown SRF transcriptionally regulates the miR-143 and miR-145 gene cluster through direct interactions with CArG boxes in their promoter region. 8, 9 As expected, levels of miR-143 ( Figure 4A and 4B) and miR-145 (not shown) were decreased in SRF-depleted SMCs. To determine whether miR-143 can directly target FRA-1 we obtained a FRA-1 3ЈUTR-luc construct and measured expression in response to SRF depletion. SRF-depleted cells exhibited increased luciferase activity, whereas expression of a miR-143 mimetic reversed the effect ( Figure 4C ), suggesting that FRA-1 is a direct target of miR-143. To confirm regulation by miR-143, we either deleted or introduced point mutations into the putative miRNA response element in the FRA-1 3Ј-UTR. Although a miR-143 mimic decreased activity of the wildtype 3Ј-UTR, it failed to alter activity in SMCs cotransfected with either the deletion or the point mutant constructs ( Figure  4D) . Concurrently, the increase in FRA-1 protein levels ( Figure 4E ) and induction of miR-21 ( Figure 4F ) observed in SRF-depleted cells was also reversed by the miR-143 mimetic. Importantly, these effects were associated with a subsequent restoration of PTEN levels in SRF-depleted SMCs to those observed in control SMCs ( Figure 4G ), as well as a functional reversal in the induction of monocyte chemoattractant protein-1 mRNA observed in SRF depleted SMCs ( Figure 4H ). We conclude that SRF-mediated regulation of miR-143 directly targets FRA-1, leading to repression of miR-21 promoter activity and subsequent release of miR-21 translational repression of PTEN. Inactivation of SRF reverses this process leading to PTEN degradation and the promotion of a proliferative, inflammatory SMC phenotype.
Platelet-Derived Growth Factor Can Regulate the SRF-Dependent miRNA Network That Controls PTEN Expression
Platelet-derived growth factor (PDGF) is a critical regulator of SMC phenotypic changes in the setting of vascular injury. 6 Previous work from our laboratory showed that PDGF decreased SM-gene expression and that this was mediated in part through a relocalization of SRF, which inactivates its transcriptional activity. 20 We therefore examined whether PDGF, as a physiological stimulus, also regulates the SRFdependent miRNA network that controls PTEN expression. Similar to SRF-depleted SMCs, PDGF stimulation of early passage SMCs resulted in decreased miR-143 transcripts levels ( Figure 5A ), increased FRA-1 protein levels ( Figure  5B) , and a complementary increase in miR-21 transcripts levels ( Figure 5C ). Consistent with the changes in this miR network, PDGF stimulation led to a decrease in PTEN protein levels ( Figure 5D ). Thus, we conclude that a physiological stimulus such as PDGF that regulates SRF activity may be sufficient to regulate PTEN through an SRF-dependent miR-143-FRA-1-miR-21 network.
Discussion
SRF has been implicated as a critical regulator of 2 classes of genes: immediate early genes and muscle-specific genes. 6, 25 In SMCs, these genes are associated with enhanced proliferation and promotion of differentiation, respectively. It would therefore be anticipated that inhibition of SRF transcriptional activity would result in dedifferentiated SMCs because of loss of SM-gene expression, combined with decreased proliferation as a result of loss of IEG expression. To model inactivation of SRF, using shRNA approaches, we generated SMCs that were silenced for expression of the protein. 10 Although these cells showed the expected decreases in SM-gene and IEG expression, we made the unanticipated finding that SRF-depleted SMCs had higher rates of proliferation and migration. The goal of the current study was to identify the mechanism underlying this enhanced proliferation in the setting of SRF depletion. Here, we describe an alternative proliferative pathway that is activated in the Figure 6 ).
Our work implicates PTEN as a downstream effector of SRF, which controls reprogramming of SMCs into a proliferative, inflammatory phenotype. Depletion of SRF decreased PTEN expression, whereas reexpression of PTEN in SRF-depleted SMCs reversed the increased proliferation and cytokine/chemokine production observed in the SRF silenced cells. This is the first report to our knowledge linking SRF to PTEN in SMCs. In contrast to the effects on proliferation and cytokine/chemokine production, regulation of SM-gene expression was independent of PTEN status in SRF-depleted cells. This was anticipated, because SRF is the primary transcription factor that regulates the expression of many SM genes through direct binding to multiple CArG boxes in the promoter region of these genes. However, recent work from our laboratory has shown that PTEN regulates SM-gene expression. 17 A potential explanation for this apparent inconsistency is that PTEN may regulate SRF activity through a potential feedback loop to regulate SM-gene expression. In the setting of constitutive SRF depletion by shRNA, any regulation of SRF by PTEN may be masked; thus, reintroduction of PTEN would be predicted to have no effect on SM-gene expression.
Our data also demonstrate that regulation of PTEN expression by SRF is mediated through an miRNA network ( Figure 6 ). Previous work has identified specific miRs whose promoter regions contain CArG boxes, as direct targets of SRF. 8, 9 Consistent with these studies, we have observed decreased levels of miR-143 in the setting of SRF depletion and demonstrated that this is critical for regulation of PTEN. Furthermore, SRF depletion results in increased levels of miR-21, which mediates the decreased expression of PTEN. Induction of miR-21 in turn is transcriptionally regulated and involves increased expression of the transcription factor FRA-1 through loss of miR-143 repression.
AP-1 transcription factors are heterodimeric proteins composed of fos and jun family members which bind to consensus sites (TPA response element) in the promoters of target genes. Under conditions of SRF depletion, we previously showed a marked decrease in c-fos and a significant increase in c-jun levels. 10 Here we report that loss of miR-143 as a consequence of SRF depletion results in increased expression of the fos family member FRA-1. Importantly, our data demonstrate that SRF regulates transcription factors of the same family in opposite directions and by alternative mechanisms. It is well established that c-fos, which has a serum response element in its promoter region, is directly and positively regulated transcriptionally by SRF. 24 Interestingly, FRA-1 also has a CArG box within its promoter region, which is required for basal level transcription. However, if the predominant mechanism mediating FRA-1 is through direct SRF-induced transcriptional regulation, then levels should decrease in the setting of SRF depletion similar to c-fos. In fact, FRA-1 levels change in the opposite direction to c-fos, and our data demonstrating alterations in the 3Ј-UTR strongly support a model in which FRA-1 is a direct target of miR-143. Thus, decreased SRF will result in decreased miR-143 levels and subsequent release of the negative regulation of FRA-1.
We propose that FRA-1/c-jun heterodimers regulate transcription of miR-21, which in turn decreases PTEN expression. miR-21 has been shown to be increased in the setting of vascular injury, and blocking miR-21 has been shown to reduce neointima progression. 18 Several studies, including the present one, have demonstrated that PTEN is a direct target of miR-21 in SMCs. Moreover, an inverse correlation between miR-143 and miR-21 in the setting of vascular injury has been previously reported. 8, 18 Our data are consistent with these findings, because both neointimal SMCs in vivo and SRF-depleted cells in vitro are characterized by a dedifferentiated, proliferative, and inflammatory phenotype. It will therefore be of interest to determine whether induction of FRA-1 occurs after injury and mediates miR-21 induction in vivo. In addition to our report, several reports in the cancer field have shown an inverse correlation between miR-143 and miR-21 levels. 26, 27 Thus, the pathway described here in SMCs may have more global consequences by contributing to the modulation of differentiation in other cell types.
Although our data strongly support an alternative proliferative and inflammatory pathway induced in the setting of SRF inactivation, it is important to note that others have reported reduced proliferation and migration in small interfering RNAmediated human coronary artery smooth muscle cells. 28 At this time, we cannot explain the discrepancies in our findings compared with this recent report, but potential reasons could include differences in cell type (rat aortic versus human coronary artery) or differences in SRF silencing approaches (shRNA versus small interfering RNA). For our study, we analyzed 2 separate isolates of stable SRF shRNA-expressing SMC clones, as well as several individual transient pools of SRF shRNA-expressing SMCs and obtained similar results. The novel pathway focusing on an SRF-PTEN axis identified here was activated in both sets of SRF-silenced SMCs and is consistent with our previously published data regarding PTEN regulation of SMC function. 17 Finally, we have demonstrated the significance of this pathway in wild-type SMCs in response to the physiological mediator PDGF. Several groups, including us, have shown that PDGF blunts SRF-dependent SM-gene expression, likely through inactivation of SRF transcriptional activity. In this context, we showed that PDGF similarly activates the miR-143-FRA-1-miR-21 axis resulting in decreased PTEN levels. Silencing of shSRF is intended to model inactivation of this transcription factor. In spite of extensive publications, the regulation of SRF is still not completely understood. It is likely that activity of SRF is regulated through transcriptional control, as well as posttranslational modifications, including phosphorylation 29, 30 and SUMOylation, 31 and changes in subcellular localization. 20 These events are likely to alter the interactions with coactivators, such as myocardin family members. It will therefore be critical to define how these regulatory events affect regulation of downstream miRs. 
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